BRCA2 and neoplasm: For example, in experimental models, though a BRCA2 reversion is able to restore HR and cause PARPi resistance, it does not restore a normal diploid genome to tumour cells; PARPi‐resistant BRCA2‐revertant cells retain a highly disordered genome and are still p53 mutant [173].